Cue Biopharma, Inc. (CUE)

26.76 +3.58 (+15.44%) USD  |  NASDAQ  |  Aug 25, 16:00
26.74 -0.02 (-0.07%) After-Hours: 04:25
More

Cue Biopharma EPS Estimates for Next Quarter

EPS Estimates for Next Quarter Chart

View EPS Estimates for Next Quarter for CUE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Estimates for Next Quarter Chart
Start Trial

Historical EPS Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
November 28, 2025 --
November 18, 2025 --
November 17, 2025 --
August 22, 2025 --
August 13, 2025 --
May 23, 2025 --
May 19, 2025 --
April 21, 2025 --
April 15, 2025 --
April 02, 2025 --
April 01, 2025 --
November 18, 2024 --
November 15, 2024 --
November 11, 2024 --
Date Value
September 27, 2024 --
August 20, 2024 --
August 19, 2024 --
July 29, 2024 --
July 26, 2024 --
July 25, 2024 --
June 06, 2024 --
June 04, 2024 --
May 16, 2024 --
May 10, 2024 --
April 09, 2024 --
April 03, 2024 --
March 13, 2024 --
February 19, 2024 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Next Quarter Range, Past 5 Years

View EPS Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for Next Quarter Benchmarks

View EPS Estimates for Next Quarter Benchmarks
Start Trial
Ironwood Pharmaceuticals, Inc. Upgrade
Fortress Biotech, Inc. Upgrade
Equillium, Inc. Upgrade
Legend Biotech Corp. Upgrade
Nurix Therapeutics, Inc. Upgrade

EPS Estimates for Next Quarter Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade